🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to determine the effect of multiple doses of Epano...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01486433
Treatments Being Tested
This is a double-blind, randomized, olive oil-controlled study to investiga...
Status
Completed
Location
Research Site
Start Date
2013-12-16
Trial ID
NCT02009865
This study is a randomized, open-label, cross-over study in healthy subject...
Status
Completed
Location
Research Site
Start Date
2015-02-12
Trial ID
NCT02359045
The primary objective is to evaluate the efficacy of adding Epanova (2 g or...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01408303
Treatments Being Tested
The primary objective of this study is to determine the effect of Epanova® ...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01431690
Treatments Being Tested
This is a randomized, open-label crossover study. The primary objective of ...
Status
Completed
Location
Research Site
Start Date
2014-10
Trial ID
NCT02189252
This study is a double-blind randomized, placebo-controlled, parallel-group...
Status
Completed
Location
Research Site
Start Date
2015-09-01
Trial ID
NCT02354976
Treatments Being Tested
The objectives of this study are to compare the relative bioavailabilities ...
Status
Completed
Location
Radiant Research
Start Date
2010-09
Trial ID
NCT01208961
Treatments Being Tested
The purpose of this study is to explore the safety, tolerability, and PK of...
Status
Completed
Location
Research Site
Start Date
2018-06-04
Trial ID
NCT03574142
Treatments Being Tested
The study is a randomized, double-blind, placebo-controlled (corn oil), par...
Status
Completed
Location
Research Site
Start Date
2014-10-30
Trial ID
NCT02104817
Treatments Being Tested